Global Cell Solutions, headquartered in Charlottesville, Virginia, is focused on the application of a novel and dramatically improved patent-pending cell culturing technique. Global Cell is positioned to be an integral partner to the next generation of scientific breakthroughs in medicine, research, biotechnology, pharmaceuticals and the emerging field of orthobiologics.
Partnering with the Medical Automation Research Center at the University of Virginia’s School of Medicine, GCS was awarded a STTR Phase I grant from the National Cancer Institute at the National Institutes of Health. This grant supports the R&D efforts for the development and production our microcarriers and automation platforms for various cell culture applications.
Global Cell technology is already establishing itself as an indispensable tool for improving research efficiency through higher cellquality and production by employing the latest in three-dimensional biology paradigms.
With the breadth of applications afforded by our core technologies, a key component of Global Cell business strategy is to form relationships with industry leaders to leverage each other's strengths and bring valuable product combinations to the market. We are currently in discussions with several potential industry partners regarding potential licensing of our cell culture solution as well as collaborative research agreements. Global Cell would like to invite you to explore the ways that we can help your company expand its market potential and deliver your customers cell culture solutions and related tools they need to accelerate the pace of their research and bioproduction